ClassID:

21647

A61K2300/00 - page 35 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#10201
20100324127
2010-12-23

TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN

#10202
20100324120
2010-12-23

Lipid formulation

#10203
20100324111
2010-12-23

COMBINATION COMPRISING PYRROLIDONE-5-CARBOXYLIC ACID AND AT LEAST ONE COMPOUND FROM CITRULLINE, ARGININE AND ASPRAGINE, AND USE THEREOF IN THE TRATMENT OF ATOPIC DERMATITIS

#10204
20100324087
2010-12-23

COMBINED USE OF ANGIOGENESIS INHIBITOR AND TAXANE

#10205
20100324083
2010-12-23

Combinations of Organic Compounds

#10206
20100324075
2010-12-23

THERAPEUTIC USE OF CARBOXYL ESTER LIPASE INHIBITORS

#10207
20100324060
2010-12-23

PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING HCV

#10208
20100324059
2010-12-23

PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING HCV

#10209
20100324050
2010-12-23

INHIBITORS OF BRUTON'S TYROSINE KINASE

#10210
20100324034
2010-12-23

Methods of Using SAHA for Treating HIV Infection

#10211
20100324031
2010-12-23

Aqueous pharmaceutical compositions containing borate-polyol complexes

#10212
20100324002
2010-12-23

Inhaled combination therapy

#10213
20100323998
2010-12-23

TOPICAL COMPOSITION CONTAINING THE COMBINATION OF MUPIROCIN AND BECLOMETHASONE

#10214
20100323997
2010-12-23

Method of treating female sexual dysfunction with a PDE1 inhibitor

#10215
20100323991
2010-12-23

METHODS AND PRODUCTS FOR TREATMENT OF DISEASES

#10216
20100323989
2010-12-23

PHARMACEUTICAL COMBINATIONS USEFUL FOR TREATING HCV

#10217
20100323987
2010-12-23

COMBINATIONS OF RETIGABINE AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAINS

#10218
20100323985
2010-12-23

PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME

#10219
20100323982
2010-12-23

Food composition for prodromal dementia patients

#10220
20100323979
2010-12-23

METHODS AND COMPOSITIONS FOR INHIBITING PROLIFERATION OF ANEUPLOID CELLS

#10221
20100323972
2010-12-23

NON-IMMUNOSUPPRESSIVE CYCLOSPORIN FOR THE TREATMENT OF MUSCULAR DYSTROPHY

#10222
20100323955
2010-12-23

METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERS

#10223
20100323952
2010-12-23

Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections

#10224
20100323043
2010-12-23

Antimicrobial Compositions and Methods of Making and Using the Same

#10225
20100323041
2010-12-23

METHODS AND THERAPEUTIC COMPOSITIONS COMPRISING PLANT EXTRACTS FOR THE TREATMENT OF CANCER

#10226
20100323040
2010-12-23

COSMETIC COMPOSITION FOR TOPICAL USE COMPRISING WASABI

#10227
20100323034
2010-12-23

Method for determination of sensitivity to anti-cancer agent

#10228
20100323032
2010-12-23

Agent for treating ulcer

#10229
20100323031
2010-12-23

Synergistic combination to enhance blood glucose and insulin metabolism

#10230
20100323030
2010-12-23

Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use

#10231
20100323028
2010-12-23

METHOD AND COMPOSITION FOR TREATING PULMONARY HEMORRHAGE

#10232
20100323008
2010-12-23

Solid dosage form comprising a fibrate

#10233
20100323004
2010-12-23

Non-pegylated liposomal doxorubicin triple combination therapy

#10234
20100322992
2010-12-23

Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device

#10235
20100322976
2010-12-23

TONIC AND FOOD SUPPLEMENT COMPRISING ALOE VERA AND HONEY

#10236
20100322942
2010-12-23

THERAPEUTIC AND PROPHYLACTIC METHODS FOR NEUROMUSCULAR DISORDERS

#10237
20100322939
2010-12-23

NOVEL METHODS FOR TREATING EGFR-ASSOCIATED TUMORS

#10238
20100322915
2010-12-23

Protease variants for pharmaceutical use

#10239
20100322912
2010-12-23

Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients

#10240
20100322904
2010-12-23

COMPOSITION COMPRISING BIFIDOBACTERIUM INFANTIS AND FRUCTO- AND GALACTO-OLIGOSACCHARIDES FOR THE PREVENTION OF INTESTINAL DISCOMFORT IN INFANTS

#10241
20100322902
2010-12-23

Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle

#10242
20100322900
2010-12-23

Treatment of multiple sclerosis with laquinimod

#10243
20100322899
2010-12-23

Methods of improving central nervous system functioning

#10244
20100322897
2010-12-23

CHARACTERIZATION OF IL-17F AND IL-17R INTERACTIONS

#10245
20100322895
2010-12-23

T CELL DEPLETING COMPOSITIONS USEFUL FOR TREATING CANCER

#10246
20100322894
2010-12-23

Combination therapies for treating type 1 diabetes

#10247
20100322891
2010-12-23

Immuniostimulating polyphosphazene compounds

#10248
20100322873
2010-12-23

BEVERAGE COMPRISING ARGININE

#10249
20100322872
2010-12-23

NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS

#10250
20100322849
2010-12-23

ENHANCED B CELL CYTOTOXICITY OF CDIM BINDING ANTIBODY

#10251
20100318120
2010-12-16

HEMOSTATIC MATERIAL AND DELIVERY DEVICE

#10252
20100318040
2010-12-16

Catheter locking solution having antimicrobial and anticoagulation properties

#10253
20100317738
2010-12-16

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH NEURONAL DYSFUNCTION

#10254
20100317734
2010-12-16

FREE FATTY ACID BLENDS AND USE THEREOF

#10255
20100317729
2010-12-16

NEW PHARMACEUTICAL FORMULATION COMPRISING CANNABIDIOL AND TETRAHYDROCANNABIDIVARIN

#10256
20100317715
2010-12-16

METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS

#10257
20100317667
2010-12-16

1-aryl- or 1-heteroaryl-pyrido[B]indoles and uses thereof in treating cancers

#10258
20100317666
2010-12-16

Composition Comprising An NK-1 Receptor Antagonist And An SSRI For The Treatment Of Tinnitus And Hearing Loss

#10259
20100317636
2010-12-16

REDUCING THE RISK OF CHRONIC LUNG DISEASE IN INFANTS

#10260
20100317617
2010-12-16

Silver nanoparticles as anti-microbial

#10261
20100317602
2010-12-16

Nutritive compositions and methods of using same

#10262
20100317597
2010-12-16

Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders

#10263
20100317594
2010-12-16

Methods for treating breast cancer using NRIF3 related molecules

#10264
20100317586
2010-12-16

Method for topical treatment of eye disease and composition and device for said treatment

#10265
20100317583
2010-12-16

TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH AN ANTINEOPLASTIC HEAT SHOCK APOPTOSIS ACTIVATOR (HSAA)

#10266
20100317575
2010-12-16

PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE

#10267
20100317574
2010-12-16

Diketopiperazine microparticles with defined isomer contents

#10268
20100317572
2010-12-16

PHARMACEUTICAL COMPOSITION COMPRISING TESOFENSINE OR ITS ANALOGUE AND AN ANTI-OBESITY COMPOUND

#10269
20100317570
2010-12-16

Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor

#10270
20100317565
2010-12-16

Novel Peptides and Their Use for the Treatment of Edema

#10271
20100317109
2010-12-16

FACTOR

#10272
20100317028
2010-12-16

Bioassay method for yokukansan with serotonin receptor

#10273
20100316769
2010-12-16

DIETARY SUPPLEMENTS CONTAINING PROBIOTICS

#10274
20100316768
2010-12-16

Nutritionally Fortified Liquid Composition With Added Value Delivery Systems/Elements/Additives

#10275
20100316758
2010-12-16

Nutritional supplement

#10276
20100316750
2010-12-16

CHOLESTEROL LOWERING SUPPLEMENT

#10277
20100316747
2010-12-16

Combinations of herb extracts having synergistic antioxidant effect, and methods relating thereto

#10278
20100316742
2010-12-16

Systems and methods for treating fibromyalgia

#10279
20100316739
2010-12-16

Chitosan gel for dermatological use, production method therefor and use of same

#10280
20100316737
2010-12-16

HOMEOPATHIC COMPLEX

#10281
20100316735
2010-12-16

COMPOSITIONS AND METHODS FOR REDUCING HANGOVER SYMPTOMS

#10282
20100316734
2010-12-16

METHODS OF THERMOGRAPH-GUIDED MEDICAL TREATMENT

#10283
20100316733
2010-12-16

Hyperbaric Oxygen Therapy and Treatment Method

#10284
20100316732
2010-12-16

BEVERAGE COMPOSITIONS FOR THE PROMOTION OF JOINT HEALTH IN COMPANION ANIMALS

#10285
20100316727
2010-12-16

TREATMENT OF INFLAMMATORY DISORDERS WITH OZONE

#10286
20100316714
2010-12-16

Methods of treating disease with random copolymers

#10287
20100316712
2010-12-16

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS

#10288
20100316708
2010-12-16

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

#10289
20100316701
2010-12-16

Compositions and method for manipulating PIM-1 activity in circulatory system cells

#10290
20100316700
2010-12-16

SYSTEMIC ADMINISTRATION OF LIPOSOMAL REDUCED GLUTATHIONE FOR THE DECORPORATION OF RADIOACTIVE MATERIALS AND NON-RADIOACTIVE MERCURY

#10291
20100316692
2010-12-16

Product and method for reducing substance craving

#10292
20100316685
2010-12-16

Dental uses of silver hydrosol

#10293
20100316640
2010-12-16

Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization

#10294
20100316639
2010-12-16

BIOMARKERS FOR IGF-1R INHIBITOR THERAPY

#10295
20100316638
2010-12-16

Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs

#10296
20100316637
2010-12-16

Compositions and methods for diagnosing and treating cancer

#10297
20100316636
2010-12-16

Method of treating rheumatoid arthritis with an IL-6R antibody

#10298
20100316621
2010-12-16

PROPHYLATIC AGENT FOR AUTOIMMUNE DISEASE

#10299
20100316614
2010-12-16

COMPOSITIONS AND METHODS FOR URINARY BLADDER REGENERATION

#10300
20100316609
2010-12-16

Conditionally Replicating Viruses for Cancer Therapy

#10301
20100316607
2010-12-16

Hepatitis C virus inhibitors

#10302
20100316594
2010-12-16

MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS

#10303
20100316591
2010-12-16

Bioabsorbable polymers

#10304
20100316580
2010-12-16

ORAL CARE PRODUCT AND METHODS OF USE THEREOF

#10305
20100316566
2010-12-16

RADIOLABELED HEDGEHOG DERIVATIVES FOR IMAGING AND THERAPY

#10306
20100311831
2010-12-09

Reduction of sterols and other compounds from oils

#10307
20100311791
2010-12-09

N-halogenated amino compounds and derivatives

#10308
20100311785
2010-12-09

Combination Therapy For Modulating The Human Sexual Response

#10309
20100311774
2010-12-09

Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer

#10310
20100311738
2010-12-09

Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists

#10311
20100311725
2010-12-09

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

#10312
20100311724
2010-12-09

Noribogaine in the treatment of pain and drug addiction

#10313
20100311723
2010-12-09

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

#10314
20100311722
2010-12-09

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

#10315
20100311719
2010-12-09

Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication

#10316
20100311717
2010-12-09

METHODS AND COMPOSITIONS FOR RETARDING WEIGHT GAIN ASSOCIATED WITH USE OF ATYPICAL ANTIPSYCHOTIC DRUGS

#10317
20100311706
2010-12-09

METHOD OF TREATMENT OF ALLERGIC RHINITIS

#10318
20100311700
2010-12-09

Transdermal preparation for external use containing nonsterioidal antiinflammatory/analgesic agent

#10319
20100311697
2010-12-09

Methods and compositions for the treatment of CNS-related conditions

#10320
20100311689
2010-12-09

Combination therapy with organic arsenicals

#10321
20100311679
2010-12-09

Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines

#10322
20100311678
2010-12-09

METHODS AND COMPOSITIONS FOR TREATING CANCER AND MODULATING SIGNAL TRANSDUCTION AND METABOLISM PATHWAYS

#10323
20100311674
2010-12-09

PHARMACEUTICAL COMPOSITIONS WITH A MECHANISM OF MULTI-TARGET RECEPTOR RETROACTION FOR TREATING DEPRESSION

#10324
20100311668
2010-12-09

PERSONAL CARE AND COSMETIC COMPOSITION CONTAINING TETRAPEPTIDES WITH THE MOTIFS GX1X2G, PX1X2P, OR PX1X2K

#10325
20100311665
2010-12-09

Method and composition for potentiating an opiate analgesic

#10326
20100311643
2010-12-09

USE OF GLP-1 AS A THERAPEUTIC AGENT

#10327
20100311642
2010-12-09

USE OF V2 RECEPTOR ANTAGONISTS IN COMBINATION WITH VASO PRESSINERGIC AGNOSTS

#10328
20100311639
2010-12-09

Inhibitors of NCchannels for therapy

#10329
20100310726
2010-12-09

Novel Preparation of an Enteric Release System

#10330
20100310690
2010-12-09

Pharmaceutical product and analysis model for hormone replacement therapy for women and prevention of some cancers and uterine myomas

#10331
20100310688
2010-12-09

ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE

#10332
20100310683
2010-12-09

PHARMACEUTICAL COMPOSITIONS FOR TREATING DEPRESSION AND ANXIETY

#10333
20100310682
2010-12-09

PHARMACEUTICAL COMPOSITIONS FOR TREATING ANXIETY

#10334
20100310681
2010-12-09

Modulation of KCNQ potassium channel activity for treatment of psychiatric disorders and the symptoms thereof

#10335
20100310680
2010-12-09

COMPOSITION AND METHOD FOR TREATING ACNE

#10336
20100310678
2010-12-09

Compositions and Methods for Nutrition Supplementation

#10337
20100310677
2010-12-09

Stable amorphous calcium carbonate comprising phosphorylated amino acids

#10338
20100310674
2010-12-09

NOVEL COMPOSITION FOR TREATING THE SIDE EFFECTS OF ANTICANCER TREATMENTS

#10339
20100310665
2010-12-09

BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS

#10340
20100310664
2010-12-09

Compositions and methods for treating insulin resistance and diabetes mellitus

#10341
20100310654
2010-12-09

HOMEOPATHIC REMEDIES FOR USE BEFORE AND AFTER AESTHETIC INJECTABLE AND SURGICAL PROCEDURES TO MINIMIZE SWELLING AND BRUISING

#10342
20100310650
2010-12-09

Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation

#10343
20100310641
2010-12-09

Therapeutic approaches for treating CMT and related disorders

#10344
20100310638
2010-12-09

Liposomes comprising duramycin and anti-viral agents

#10345
20100310626
2010-12-09

ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR BONE REGENERATION

#10346
20100310609
2010-12-09

COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

#10347
20100310581
2010-12-09

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)

#10348
20100310574
2010-12-09

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF STATIN-INDUCED MYOPATHY

#10349
20100310570
2010-12-09

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

#10350
20100310554
2010-12-09

Methods for Reversing Multiple Resistance in Animal Cells

#10351
20100310547
2010-12-09

Treatment of inflammatory diseases

#10352
20100310545
2010-12-09

Dry treatment mixture and methods of production and use

#10353
20100310544
2010-12-09

COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES

#10354
20100310542
2010-12-09

Pharmaceutical Compositions for treating wouds and related methods

#10355
20100310524
2010-12-09

Compositions suitable for treatment of spinal disease, disorder or condition

#10356
20100310507
2010-12-09

Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy

#10357
20100310497
2010-12-09

Pharmaceutical composition or combination drug

#10358
20100310477
2010-12-09

Pharmaceutical compositions based on anticholingerics and additional active ingredients

#10359
20100310471
2010-12-09

ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES

#10360
20100310469
2010-12-09

VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#10361
20100310454
2010-12-09

COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND /OR THEIR CANCEROUS COUNTERPART

#10362
20100308282
2010-12-09

Medical electrode containing a hydrophilic polymer

#10363
20100305498
2010-12-02

Gas mist pressure bath system

#10364
20100305204
2010-12-02

COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS

#10365
20100305199
2010-12-02

THERAPEUTIC REGIMEN FOR TREATING CANCER

#10366
20100305183
2010-12-02

METHOD AND COMPOSITION FOR REDUCING REPERFUSION INJURY

#10367
20100305178
2010-12-02

Pharmaceutical composition

#10368
20100305172
2010-12-02

Methods for concomitant administration of colchicine and a second active agent

#10369
20100305171
2010-12-02

Methods for concomitant administration of colchicine and a second active agent

#10370
20100305163
2010-12-02

PHARMACEUTICAL FORMULATIONS COMPRISING NSAID AND PROTON PUMP INHIBITOR DRUGS

#10371
20100305160
2010-12-02

Anesthetic methods and compositions

#10372
20100305151
2010-12-02

O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders

#10373
20100305130
2010-12-02

NASAL SPRAY DEVICE AND METHOD OF USE THEREOF

#10374
20100305102
2010-12-02

Heterocycle-substituted piperazino-dihydrothienopyrimidines

#10375
20100305095
2010-12-02

Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs

#10376
20100305086
2010-12-02

Pharmaceutical compositions for the treatment of pain

#10377
20100305079
2010-12-02

Method of treating human preeclampsia employing resibufagenin

#10378
20100305075
2010-12-02

Composition and method of treating hearing loss

#10379
20100305074
2010-12-02

NIACIN-BASED PHARMACEUTICAL COMPOSITIONS

#10380
20100305057
2010-12-02

Synergistic pharmaceutical combination for the treatment of cancer

#10381
20100305054
2010-12-02

CONCENTRATED AQUEOUS AZALIDE FORMULATIONS

#10382
20100305048
2010-12-02

NOVEL USE OF CYTOKINE INHIBITORS

#10383
20100305035
2010-12-02

Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative

#10384
20100303937
2010-12-02

NOVEL COMPOSITION TO INCREASE TESTOSTERONE LEVELS

#10385
20100303936
2010-12-02

METHOD OF REDUCING FAT ACCUMULATION AND INDUCING WEIGHT LOSS

#10386
20100303935
2010-12-02

Medicinal Composition

#10387
20100303932
2010-12-02

Method for Attenuating the Effects of Botulinum Toxin

#10388
20100303925
2010-12-02

REMINERALISATION OF CALCIFIED TISSUE

#10389
20100303921
2010-12-02

Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan

#10390
20100303918
2010-12-02

COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISORDERS

#10391
20100303904
2010-12-02

Tablet with remedial composition and methods for treating medical disorders and ailments

#10392
20100303903
2010-12-02

METHODS OF ENHANCING SELECTIVE SEROTONIN REUPTAKE INHIBITOR EFFECTS IN MAMMALS

#10393
20100303894
2010-12-02

treatment

#10394
20100303887
2010-12-02

DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells

#10395
20100303877
2010-12-02

Controlled Release Hydrogel Films

#10396
20100303871
2010-12-02

COMPOSITIONS AND METHODS FOR MODULATING CELLULAR MEMBRANE-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION

#10397
20100303870
2010-12-02

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

#10398
20100303855
2010-12-02

METHOD OF REDUCING ADVERSE EFFECTS OF THERAPEUTIC AGENTS FOR DYSLIPIDEMIA

#10399
20100303854
2010-12-02

Botanical anti-acne formulations

#10400
20100303839
2010-12-02

Methods and compositions for treatment of cancer using oncolytic RSV activity

#10401
20100303836
2010-12-02

Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent

#10402
20100303825
2010-12-02

Anti-estrogen and immune modulator combinations for treating breast cancer

#10403
20100303815
2010-12-02

METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra

#10404
20100303810
2010-12-02

METHOD FOR TREATING LUPUS

#10405
20100303799
2010-12-02

Treatment of conditions related to shock

#10406
20100303797
2010-12-02

Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes

#10407
20100303795
2010-12-02

MARKER OF PROSTATE CANCER

#10408
20100303793
2010-12-02

COMBINATION THERAPY FOR CARDIAC REVASCULARIZATION AND CARDIAC REPAIR

#10409
20100303784
2010-12-02

Preparation for the prevention and/or treatment of vascular disorders

#10410
20100303769
2010-12-02

Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease

#10411
20100303760
2010-12-02

TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS

#10412
20100303742
2010-12-02

Skin compositions containing hydrocortisone

#10413
20100303719
2010-12-02

Anti-cancer compounds

#10414
20100301268
2010-12-02

Multi-part substitution infusion fluids and matching anticoagulants

#10415
20100298433
2010-11-25

Branched chain fatty acids for prevention or treatment of gastrointestinal disorders

#10416
20100298429
2010-11-25

Continuous administration of dopa decarboxylase inhibitors and compositions for same

#10417
20100298428
2010-11-25

Continuous administration of dopa decarboxylase inhibitors and compositions for same

#10418
20100298421
2010-11-25

Derivatives of taxol and closely related compounds

#10419
20100298412
2010-11-25

Disulfide chemotherapeutic agents and methods of use thereof

#10420
20100298396
2010-11-25

Manufacture, compositions and uses of coagulation factor VIIa modulator

#10421
20100298379
2010-11-25

Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound

#10422
20100298375
2010-11-25

MEDICAMENT COMPRISING A CARBOSTYRIL DERIVATIVE AND DONEPEZIL FOR TREATING ALZHEIMER'S DISEASE

#10423
20100298335
2010-11-25

Preparations and Methods for Ameliorating or Reducing Presbyopia

#10424
20100298333
2010-11-25

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

#10425
20100298294
2010-11-25

Ketone bodies and ketone body esters as blood lipid lowering agents

#10426
20100298279
2010-11-25

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

#10427
20100298276
2010-11-25

Thyroid receptor ligands

#10428
20100298268
2010-11-25

Controlled release formulations of levodopa and uses thereof

#10429
20100298261
2010-11-25

Edible compositions for lowering cholesterol

#10430
20100298259
2010-11-25

PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME

#10431
20100298258
2010-11-25

Analgesic compositions

#10432
20100298254
2010-11-25

ORGAN ARREST, PROTECTION AND PRESERVATION

#10433
20100298250
2010-11-25

Compositions and methods for extracting and using phytochemicals for the treatment of influenza

#10434
20100298249
2010-11-25

PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME

#10435
20100298244
2010-11-25

COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF HELICOBACTER PYLORI INFECTION

#10436
20100298243
2010-11-25

COMBINATION THERAPY WITH SGLT-2 INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS

#10437
20100298230
2010-11-25

USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS

#10438
20100298222
2010-11-25

Use of an agent that restores tissue perfusion and oxygenation

#10439
20100298208
2010-11-25

Biofilm prevention using lactoferrin

#10440
20100298205
2010-11-25

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO GASTRIC ACID SECRETION

#10441
20100297760
2010-11-25

PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF PROSTATE CANCER

#10442
20100297689
2010-11-25

Placental stem cell populations

#10443
20100297271
2010-11-25

Compositions and methods for reducing hepatotoxicity associated with drug administration

#10444
20100297270
2010-11-25

COMPOSITION FOR TREATMENT OF ISCHEMIC HEART DISEASE, FACILITATION OF BLOOD CIRCULATION AND ANGIOGENESIS, IMPROVING SKIN BEAUTY, IMPROVING MALE SEXUAL FUNCTION CONTAINING GINSENG BERRY EXTRACT

#10445
20100297267
2010-11-25

Compositions for diabetes treatment and prophylaxis

#10446
20100297265
2010-11-25

Optimal compositions and methods for treating oral disease and pain

#10447
20100297263
2010-11-25

COLON CLEANSING COMPOSITIONS AND METHODS

#10448
20100297262
2010-11-25

PHARMACEUTICALLY ACTIVE COMPOSITIONS COMPRISING OXIDATIVE STRESS MODULATORS (OSM), NEW CHEMICAL ENTITIES, COMPOSITIONS AND USES

#10449
20100297254
2010-11-25

Nutraceutical composition and methods of use

#10450
20100297230
2010-11-25

COMPOSITIONS AND METHODS FOR PROSTATE AND MENSTRUAL/MENOPAUSAL RELATED HEALTH

#10451
20100297229
2010-11-25

TAPENTADOL COMPOSITIONS

#10452
20100297200
2010-11-25

Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents

#10453
20100297193
2010-11-25

Methods of therapeutic treatment of eyes

#10454
20100297181
2010-11-25

AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ

#10455
20100297142
2010-11-25

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy

#10456
20100297132
2010-11-25

Monoclonal antibody

#10457
20100297123
2010-11-25

COMBINATION THERAPY TO INHIBIT T CELL EFFECTOR FUNCTION

#10458
20100297121
2010-11-25

Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists

#10459
20100297118
2010-11-25

Therapeutic Cancer Treatments

#10460
20100297113
2010-11-25

Quinone derivatives, pharmaceutical compositions, and uses thereof

#10461
20100297112
2010-11-25

COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER

#10462
20100297095
2010-11-25

Method to treat and prevent skin diseases with Porifera-based therapeutic compositions treating and preventing skin diseases

#10463
20100297086
2010-11-25

Bacteriophage preparations and methods of use thereof

#10464
20100297075
2010-11-25

COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

#10465
20100297074
2010-11-25

Wound healing compositions, systems, and methods

#10466
20100297072
2010-11-25

Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy

#10467
20100297071
2010-11-25

Immune response inducer

#10468
20100297064
2010-11-25

Cytokine zalpha11 ligand antibodies

#10469
20100297063
2010-11-25

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

#10470
20100297060
2010-11-25

ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY COMBINED TREATMENT WITH IMMUNOCYTOKINE UPTAKE ENHANCING AGENTS

#10471
20100297033
2010-11-25

Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease

#10472
20100297028
2010-11-25

MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES

#10473
20100297024
2010-11-25

Promoter inducible by reactive oxygen species and vector comprising the same

#10474
20100297020
2010-11-25

PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT

#10475
20100297008
2010-11-25

Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors

#10476
20100292791
2010-11-18

Fully synthetic implantable multi-phased scaffold

#10477
20100292650
2010-11-18

Methods and Related Compositions for Reduction of Fat and Skin Tightening

#10478
20100292344
2010-11-18

Methods and compositions for treating thalamocortical dysrhythmia

#10479
20100292336
2010-11-18

Polar hydrophilic prodrugs and non-standard amino acid conjugates of amphetamine and other stimulants and processes for making and using the same

#10480
20100292333
2010-11-18

COMPOSITIONS SUITABLE FOR THE TOPICAL TREATMENT OF FUNGAL INFECTIONS OF THE SKIN AND NAILS

#10481
20100292332
2010-11-18

Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine

#10482
20100292330
2010-11-18

COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION

#10483
20100292314
2010-11-18

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#10484
20100292309
2010-11-18

INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH

#10485
20100292281
2010-11-18

TREATMENT OF MCI AND ALZHEIMER'S DISEASE

#10486
20100292268
2010-11-18

Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use

#10487
20100292248
2010-11-18

Combination preparations comprising SLV308 and a dopamine agonist

#10488
20100292217
2010-11-18

RANOLAZINE FOR THE TREATMENT OF CNS DISORDERS

#10489
20100292216
2010-11-18

Methods and Compositions for the Treatment of Psychiatric Conditions

#10490
20100292194
2010-11-18

Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis

#10491
20100292193
2010-11-18

RADIOPROTECTIVE DRUGS

#10492
20100292185
2010-11-18

BETA-LACTAMASE INHIBITORS

#10493
20100292183
2010-11-18

TETRACYCLINE AND USES THEREOF

#10494
20100292182
2010-11-18

Cystitis treatment with high dose chondroitin sulfate

#10495
20100292178
2010-11-18

Method of treating non-insulin dependent diabetes mellitus and related complications

#10496
20100292177
2010-11-18

Methods of treatment using combination therapy

#10497
20100292157
2010-11-18

Combination Treatments for Alzheimer's Disease and Similar Diseases

#10498
20100292156
2010-11-18

Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof

#10499
20100292150
2010-11-18

Treatment of Menorrhagia with Aromatase Inhibitor

#10500
20100291589
2010-11-18

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level